Determinants of poor blood pressure control in urban hypertensives of central India

Journal of Human Hypertension

Volumn 10, Issue 5, 1996, Pages 299-303

  Joshi, P P ^a   Salkar, R G ^a   Heller, R F ^b,c  

^a GOVERNMENT MEDICAL COLLEGE   (India)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c ROYAL NEWCASTLE HOSPITAL   (Australia)

Author keywords

Blood pressure control; Compliance; Life events

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE REGULATION; BODY MASS; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; INDIA; LIFE EVENT; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; QUESTIONNAIRE; REGRESSION ANALYSIS; SMOKING; STRESS; URBAN AREA;

BLOOD PRESSURE; FEMALE; HUMANS; HYPERTENSION; INDIA; LIFE CHANGE EVENTS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; URBAN HEALTH;

EID: 0029901158     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. The Fifth Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993; 153: 154-183.
2. Management Committee: The Australian Therapeutic Trial in Mild Hypertension. Lancet 1980; 1: 1261-1267.
3. Medical Research Council Working Party, MRC Trial of Treatment of Mild Hypertension Principal Results. Br Med J Clin Res 1985; 291: 97-104.
4. Hypertension Detection and Follow-up Program Cooperative Group: 5 year findings of HDFP reduction in mortality of persons with high blood pressure. JAMA 1979; 242: 2562-2572.
5. Collins R et al. Blood pressure, stroke and coronary heart disease. Part 2, short term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827-838.
6. Smith WCS, Lee AJ, Crombie LK, Tunstall Pedoe H. Control of blood pressure in Scotland: rule of halves. Br Med J 1990; 300: 981-983.
7. Adults taking action to control their blood pressure - United States, 1990. MMWR Morb Mortal Wkly Rep 22 July 1994; 43: 509-11, 517.
8. Gupta SP, Siwachi SB, Gupta MS. Hypertension and blood pressure trends in the general population of Haryana. J Assoc Phys India 1979; 27: 119-126.
9. Sackett DL, Haynes BL, Taylor DW. The problem of compliance with antihypertensive regimens. Drugs 1983; 25 (Suppl 2): 12-18.
10. Heurtin-Roberts S, Reisin E. The relation of culturally influenced lay models of hypertension to compliance with treatment. Am J Hypertens 1992; 5: 787-792.
11. Lim TO et al. The Mentakab Hypertension Study Project. Part V: Drug compliance in hypertensive patients. Singapore Med J 1992; 33: 63-66.
12. Clark LT. Improving compliance and increasing control of hypertension: needs of special hypertensive populations. Am Heart J 1991; 121: 664-669.
13. Jones JK et al. Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population. Br Med J 1995; 311: 293-295.
14. McCombs JS, Nichol MB, Newman CM, Sclar DA. The costs of interrupting antihypertensive drug therapy in a Medicaid population. Med Car (US) 1994; 32 (3): 214-226.
15. Psaty BM et al. Temporal patterns of antihypertensive medication use among elderly patients. JAMA 1993; 270: 1837-1841.
16. 1988 Joint National Committee - The 1988 report of Joint National Committee on detection evaluation and treatment of high blood pressure. Archives of Internal Medicine 1988; 148: 1023-1038.
17. Sackett DL, Haynes RB, Tugwell P. Clinical epidemiology: a basic science for clinical medicine, First Edn. Little Brown and Company: Boston/Toronto, 1985, pp 199-222.
18. Caldwell JR et al. Psychosocial factors influence control of moderate and severe hypertension. Soc Sci Med 1983; 17: 773-782.
19. Inui TS, Carter WB, Pecoraro RE. Screening for non-compliance among patients with hypertension. Medical Care 1981; XIX: 1061-1064.
20. Morisky DE et al. Five year blood pressure control and mortality following health education for hypertensive patients. Am J Public Health 1983; 73: 153-162.
21. Wagner EH, Truesdale RA, Warner JT. Compliance, treatment practices and blood pressure control: community survey findings. J Chronic Dis 1981; 34: 519-525.
22. Rudd P et al. The natural history of medication compliance in a drug trial: Limitations of pill counts. Clin Pharmacol Ther 1989; 46: 169-176.
23. Eisen SA et al. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med 1990; 150: 1881-1884.
24. Eisen SA, Hanpeter JA, Krenger LW, Gard M. Monitoring medication compliance: description of a new device. J Comp Health Care 1987; 2: 131-142.
25. Rudd P, Marshall G. Resolving problems of measuring compliance with medication monitors. J Compliance Health Care 1987; 2: 23-35.
26. Joshi PP. Is hypertensive always a hypertensive? J Assoc Phys India 1993; 41: 765.
27. Buck CW, Donner AP. Blood pressure control in hypertensives: a model for the study of life events. J Chr Dis 1984; 4: 247-253.
28. Sesoko S, Akema N, Matsukawa T, Kaneko Y. Predisposing factors for the development of malignant hypertension. Arch Intern Med 1987; 147: 1721-1724.
29. Odio OJ, Uzogara ED. Recent life event frequencies in Nigerians with essential hypertension (letter). Hypertension 1988; 12: 330-331.
30. Isaksson H, Konarski K, Theorell T. The psychological and social condition of hypertensives resistant to pharmacological treatment. Soc Sci Med 1992; 35: 869-875.
31. Stason WB et al. Effectiveness and costs of veterans affairs hypertension clinics. Med Care 1994; 32: 1197-1215.